References
- Tao ZQi, Shi A, Lu C, Song T, Zhang Z, Zhao J. Breast cancer: Epidemiology and etiology. Cell Biochem Biophys. 2015;72(2):333–8. doi:https://doi.org/10.1007/s12013-014-0459-6
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492
- Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C, Global Burden of Disease Cancer Collaboration, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27.:doi:https://doi.org/10.1001/jamaoncol.2015.0735
- Bodai BI, Tuso P. Breast cancer survivorship: A comprehensive review of long-term medical issues and lifestyle recommendations. Perm J. 2015;19(2):48–79. doi:https://doi.org/10.7812/TPP/14-241
- Arendt LM, Kuperwasser C. Working stiff: How obesity boosts cancer risk. Sci Transl Med. 2015;7(301):301fs34 doi:https://doi.org/10.1126/scitranslmed.aac9446
- Grosso G, Bella F, Godos J, Sciacca S, Del Rio D, Ray S, Galvano F, Giovannucci EL. Possible role of diet in cancer: systematic review and multiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk. Nutr Rev. 2017;75(6):405–19. doi:https://doi.org/10.1093/nutrit/nux012
- Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23(7):1111–30. doi:https://doi.org/10.1002/sim.1668
- de Jong MM, Nolte IM, Te Meerman GJ, van der Graaf WTA, Oosterwijk JC, Kleibeuker JH, Schaapveld M, de Vries EGE. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet. 2002;39(4):225–42. doi:https://doi.org/10.1136/jmg.39.4.225
- Maalmi H, Ordonez-Mena JM, Schottker B, Brenner H. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies. Eur J Cancer. 2014;50(8):1510–21. doi:https://doi.org/10.1016/j.ejca.2014.02.006
- Huss L, Butt S, Borgquist S, Almquist M, Malm J, Manjer J. Serum levels of vitamin D, parathyroid hormone and calcium in relation to survival following breast cancer. Cancer Causes Control. 2014;25(9):1131–40. doi:https://doi.org/10.1007/s10552-014-0413-3
- Afzal S, Brondum-Jacobsen P, Bojesen SE, Nordestgaard BG. Genetically low vitamin D concentrations and increased mortality: Mendelian randomisation analysis in three large cohorts. BMJ. 2014;349:g6330 doi:https://doi.org/10.1136/bmj.g6330
- Mondul AM, Weinstein SJ, Layne TM, Albanes D. Albanes D: Vitamin D and cancer risk and mortality: state of the science, gaps, and challenges. Epidemiol Rev. 2017;39(1):28–48. doi:https://doi.org/10.1093/epirev/mxx005
- Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI. Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer. Cancer Res. 2010;70(21):8587–97. doi:https://doi.org/10.1158/0008-5472.CAN-10-1420
- Garland CF, Gorham ED, Mohr SB, Grant WB, Giovannucci EL, Lipkin M, Newmark H, Holick MF, Garland FC. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol. 2007;103(3–5):708–11. doi:https://doi.org/10.1016/j.jsbmb.2006.12.007
- Lee JE, Li H, Chan AT, Hollis BW, Lee I-M, Stampfer MJ, Wu K, Giovannucci E, Ma J. Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev Res (Phila)). 2011;4(5):735–43. doi:https://doi.org/10.1158/1940-6207.capr-10-0289
- Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P, Autier P. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer. 2011;128(6):1414–24. doi:https://doi.org/10.1002/ijc.25439
- Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer. 2010;46(12):2196–205. doi:https://doi.org/10.1016/j.ejca.2010.03.037
- Wang D, Velez de-la-Paz OI, Zhai JX, Liu DW. Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies. Tumour Biol. 2013;34(6):3509–17. doi:https://doi.org/10.1007/s13277-013-0929-2
- Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: A review (United States). Cancer Causes Control. 2005;16(2):83–95. doi:https://doi.org/10.1007/s10552-004-1661-4
- Keum N, Lee DH, Greenwood DC, Manson JE, Giovannucci E. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ann Oncol. 2019;30(5):733–43. doi:https://doi.org/10.1093/annonc/mdz059
- Chakraborti CK. Vitamin D as a promising anticancer agent. Indian J Pharmacol. 2011;43(2):113–20. doi:https://doi.org/10.4103/0253-7613.77335
- Shao T, Klein P, Grossbard ML. Vitamin D and breast cancer. Oncologist. 2012;17(1):36–45. doi:https://doi.org/10.1634/theoncologist.2011-0278
- Welsh J. Function of the vitamin D endocrine system in mammary gland and breast cancer. Mol Cell Endocrinol. 2017;453:88–95. doi:https://doi.org/10.1016/j.mce.2017.04.026
- Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM, Figueiredo JC, Ahnen DJ, Bresalier RS, Burke CA, et al. Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial. J Clin Endocrinol Metab. 2014;99(10):E2133–7. :doi:https://doi.org/10.1210/jc.2014-1389
- Zajickova K, Hill M, Vankova M, Zofkova I. Low-density lipoprotein receptor-related protein 5 and vitamin D receptor gene polymorphisms in relation to vitamin D levels in menopause. Clin Chem Lab Med. 2006;44:1066–9. doi:https://doi.org/10.1515/cclm.2006.204
- Rao Vupputuri M, Goswami R, Gupta N, Ray D, Tandon N, Kumar N. Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptor gene polymorphisms in Asian Indians. Am J Clin Nutr. 2006;83(6):1411–9. doi:https://doi.org/10.1093/ajcn/83.6.1411
- Baroncelli GI, Bereket A, El Kholy M, Audì L, Cesur Y, Ozkan B, Rashad M, Fernández-Cancio M, Weisman Y, Saggese G, et al. Rickets in the Middle East: role of environment and genetic predisposition. J Clin Endocrinol Metab. 2008;93(5):1743–50.: doi:https://doi.org/10.1210/jc.2007-1413
- Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res. 1996;11(12):1850–5. doi:https://doi.org/10.1002/jbmr.5650111204
- Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338(2):143–56. doi:https://doi.org/10.1016/j.gene.2004.05.014
- Fang Y, van Meurs JBJ, d'Alesio A, Jhamai M, Zhao H, Rivadeneira F, Hofman A, van Leeuwen JPT, Jehan F, Pols HAP, et al. Promoter and 3'-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study . Am J Hum Genet. 2005;77(5):807–23. doi:https://doi.org/10.1086/497438
- Mohseni H, Hosseini SA, Amani R, Ekrami A, Ahmadzadeh A, Latifi SM. Circulating 25-Hydroxy Vitamin D Relative to Vitamin D Receptor Polymorphism after Vitamin D3 Supplementation in Breast Cancer Women: A Randomized, Double-Blind Controlled Clinical Trial. Asian Pac J Cancer Prev. 2017;18(7):1953–9. doi:https://doi.org/10.22034/apjcp.2017.18.7.1953
- Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, Chang-Claude J. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res. 2011;13(4) doi:https://doi.org/10.1186/bcr2920
- Mohr SB, Gorham ED, Kim J, Hofflich H, Garland CF. Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer. Anticancer Res. 2014;34(3):1163–6.
- Vrieling A, Seibold P, Johnson TS, Heinz J, Obi N, Kaaks R, Flesch-Janys D, Chang-Claude J. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors? Int J Cancer. 2014;134(12):2972–83. doi:https://doi.org/10.1002/ijc.28628
- Villaseñor A, Ballard-Barbash R, Ambs A, Bernstein L, Baumgartner K, Baumgartner R, Ulrich CM, Hollis BW, McTiernan A, Neuhouser ML, et al. Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors. Cancer Causes Control. 2013;24(4):759–67.: doi:https://doi.org/10.1007/s10552-013-0158-4
- Neuhouser ML, Sorensen B, Hollis BW, Ambs A, Ulrich CM, McTiernan A, Bernstein L, Wayne S, Gilliland F, Baumgartner K, et al. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr. 2008;88(1):133–9.:doi:https://doi.org/10.1093/ajcn/88.1.133
- Reimers LL, Crew KD, Bradshaw PT, Santella RM, Steck SE, Sirosh I, Terry MB, Hershman DL, Shane E, Cremers S, et al. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk. Cancer Causes Control. 2015;26(2):187–203.:doi:https://doi.org/10.1007/s10552-014-0497-9
- Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, Wilson RG, Colston KW. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005;41(8):1164–9. doi:https://doi.org/10.1016/j.ejca.2005.01.017
- McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, Bostick RM, Thun MJ, Calle EE. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res. 2007;9(1):R9 doi:https://doi.org/10.1186/bcr1642
- Zhu Y, Wang PP, Zhai G, Bapat B, Savas S, Woodrow JR, Campbell PT, Li Y, Yang N, Zhou X, et al. Association of rs2282679 A > C polymorphism in vitamin D binding protein gene with colorectal cancer risk and survival: effect modification by dietary vitamin D intake. BMC Cancer. 2018;18(1):155:doi:https://doi.org/10.1186/s12885-018-4026-1
- O'Brien KM, Sandler DP, Kinyamu HK, Taylor JA, Weinberg CR. Single-nucleotide polymorphisms in vitamin D-related genes may modify vitamin D-breast cancer associations. Cancer Epidemiol Biomarkers Prev. 2017;26(12):1761–71. doi:https://doi.org/10.1158/1055-9965.EPI-17-0250
- Berlanga-Taylor AJ, Knight JC. An integrated approach to defining genetic and environmental determinants for major clinical outcomes involving vitamin D. Mol Diagn Ther. 2014;18(3):261–72. doi:https://doi.org/10.1007/s40291-014-0087-2
- Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, Willett WC. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int. 2010;21(7):1121–32. doi:https://doi.org/10.1007/s00198-009-1119-3
- Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.:doi:https://doi.org/10.1249/01.mss.0000078924.61453.fb
- Sesso HD, Paffenbarger RS, Jr., Lee IM. Physical activity and coronary heart disease in men: The Harvard Alumni Health Study. Circulation. 2000;102(9):975–80. doi:https://doi.org/10.1161/01.CIR.102.9.975
- Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, Petruschke RA, Chen E, de Papp AE. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005;90(6):3215–24. doi:https://doi.org/10.1210/jc.2004-2364
- Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological). 1995;57(1):289–300. doi:https://doi.org/10.1111/j.2517-6161.1995.tb02031.x
- Sinnwell JP, Schaid DJ, Sinnwell MJP. Package ‘haplo. stats’, 2018.
- Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70(2):425–34. doi:https://doi.org/10.1086/338688
- Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Hollis BW, Giovannucci E. Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25‐hydroxyvitamin D and 1, 25‐dihydroxyvitamin D, and prostate cancer risk. Prostate. 2007;67(9):911–23. doi:https://doi.org/10.1002/pros.20570
- Bodoki L, Chen J-Q, Zeher M, Nagy-Vincze M, Griger Z, Zilahi E, Dankó K. Vitamin D receptor gene polymorphisms and haplotypes in Hungarian patients with idiopathic inflammatory myopathy. Biomed Res Int. 2015;2015:809895 doi:https://doi.org/10.1155/2015/809895
- Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319–29. doi:https://doi.org/10.1016/j.chembiol.2013.12.016
- Ling Y, Lin H, Aleteng Q, Ma H, Pan B, Gao J, Gao X. Cdx-2 polymorphism in Vitamin D Receptor gene was associated with serum 25-hydroxyvitamin D levels, bone mineral density and fracture in middle-aged and elderly Chinese women. Mol Cell Endocrinol. 2016;427:155–61. doi:https://doi.org/10.1016/j.mce.2016.03.014
- Elhoseiny SM, Morgan DS, Rabie AM, Bishay ST. Vitamin D Receptor (VDR) Gene Polymorphisms (FokI, BsmI) and their Relation to Vitamin D Status in Pediatrics betaeta Thalassemia Major. Indian J Hematol Blood Transfus. 2016;32(2):228–38. doi:https://doi.org/10.1007/s12288-015-0552-z
- Vélayoudom-Céphise F-L, Larifla L, Donnet J-P, Maimaitiming S, Deloumeaux J, Blanchet A, Massart C, Munoz-Bellili N, Merle S, Chout R, et al. Vitamin D deficiency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes. Diabetes Metab. 2011;37(6):540–5.: doi:https://doi.org/10.1016/j.diabet.2011.05.005
- Valtuena J, Gonzalez-Gross M, Huybrechts I, Breidenassel C, Ferrari M, et al. Factors associated with vitamin D deficiency in European adolescents: the HELENA study. J Nutr Sci Vitaminol. 2013;59:161–71. doi:https://doi.org/10.3177/jnsv.59.161
- Almesri N, Das NS, Ali ME, Gumaa K, Giha HA. Independent associations of polymorphisms in vitamin D binding protein (GC) and vitamin D receptor (VDR) genes with obesity and plasma 25OHD3 levels demonstrate sex dimorphism. Appl Physiol Nutr Metab. 2016;41(4):345–53. doi:https://doi.org/10.1139/apnm-2015-0284
- Li L-H, Yin X-Y, Wu X-H, Zhang L, Pan S-Y, Zheng Z-J, Wang J-G. Serum 25(OH)D and vitamin D status in relation to VDR, GC and CYP2R1 variants in Chinese. Endocr J. 2014;61(2):133–41. doi:https://doi.org/10.1507/endocrj.EJ13-0369
- Jolliffe DA, Hanifa Y, Witt KD, Venton TR, Rowe M, Timms PM, Hyppönen E, Walton RT, Griffiths CJ, Martineau AR, et al. Environmental and genetic determinants of vitamin D status among older adults in London. UK. J Steroid Biochem Mol Biol. 2016;164:30–35.: doi:https://doi.org/10.1016/j.jsbmb.2016.01.005
- Serrano JCE, De Lorenzo D, Cassanye A, Martín-Gari M, Espinel A, Delgado MA, Pamplona R, Portero-Otin M. Vitamin D receptor BsmI polymorphism modulates soy intake and 25-hydroxyvitamin D supplementation benefits in cardiovascular disease risk factors profile. Genes Nutr. 2013;8(6):561–9. doi:https://doi.org/10.1007/s12263-013-0356-4
- de Medeiros Cavalcante IG, Silva AS, Costa MJC, Persuhn DC, Issa CTMI, Issa CI, de Luna Freire TL, da Conceição Rodrigues Gonçalves M. Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: Vitamin D3 megadose reduces inflammatory markers. Exp Gerontol. 2015;66:10–6. doi: 10.1016. /j.exger.2015.03.011
- Trabert B, Malone KE, Daling JR, Doody DR, Bernstein L, Ursin G, Marchbanks PA, Strom BL, Humphrey MC, Ostrander EA, et al. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res. 2007;9(6):R84: doi:https://doi.org/10.1186/bcr1833
- Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, Thammavit W. Lack of association of VDR polymorphisms with Thai prostate cancer as compared with benign prostate hyperplasia and controls. Asian Pac J Cancer Prev. 2006;7(1):136–139.
- Morton NE, Fundamentals Of Genetic Epidemiology MJ, Khoury TH, Beaty BH, Cohen N. York: Oxford University Press, 1993, 383 pages, $55.00. Genet Epidemiol. 1994;11(4):389–390. doi:https://doi.org/10.1002/gepi.1370110409
- Köstner K, Denzer N, Müller CSL, Klein R, Tilgen W, Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009;29(9):3511–36.
- O′Neill V, Asani FF, Jeffery TJ, Saccone DS, Bornman L. Vitamin D Receptor Gene Expression and Function in a South African Population: Ethnicity, Vitamin D and FokI. PLoS One. 2013;8(6):e67663. doi:https://doi.org/10.1371/journal.pone.0067663
- Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta. 2006;371(1–2):1–12. doi:https://doi.org/10.1016/j.cca.2006.02.016
- Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998;13(3):325–49. doi:https://doi.org/10.1359/jbmr.1998.13.3.325
- Levin GP, Robinson-Cohen C, de Boer IH, Houston DK, Lohman K, Liu Y, Kritchevsky SB, Cauley JA, Tanaka T, Ferrucci L, et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. Jama. 2012;308(18):1898–905. :doi:https://doi.org/10.1001/jama.2012.17304
- Datta P, Philipsen PA, Olsen P, Bogh MK, Johansen P, Schmedes AV, Morling N, Wulf HC. The half-life of 25(OH)D after UVB exposure depends on gender and vitamin D receptor polymorphism but mainly on the start level. Photochem Photobiol Sci. 2017;16(6):985–995. doi:https://doi.org/10.1039/c6pp00258g
- Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci. 2004;29(12):664–73. doi:https://doi.org/10.1016/j.tibs.2004.10.005
- McGrath JJ, Saha S, Burne THJ, Eyles DW. A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol. 2010;121(1–2):471–477. doi:https://doi.org/10.1016/j.jsbmb.2010.03.073
- Mirsaeid Ghazi AA, Rais Zadeh F, Pezeshk P, Azizi F. Seasonal variation of serum 25 hydroxy D3 in residents of Tehran. J Endocrinol Invest. 2004;27(7):676–9. doi:https://doi.org/10.1007/bf03347502